Physician profile
Frederick Schnell
NPI 1487638607
$6,113.91
in general payments reported to CMS, 2019-2025
17 companies · $16.31 in 2025
The $16.31 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2021: $14.23 · 2022: $5,154 · 2023: $493 · 2024: $32.39 · 2025: $16.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $335 · Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $335.26 |
| Food and Beverage | $206.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Labcorp Holdings INC. | $3,828.01 | 2022 | |
| Amgen INC. | $1,200.00 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $335.26 | 2023 | |
| Cardinal Health 108 LLC | $193.84 | 2019 | |
| Jazz Pharmaceuticals INC. | $126.20 | 2022 | |
| Adaptive Biotechnologies Corporation | $82.67 | 2023 | Clonoseq |
| Adc Therapeutics America, INC. | $75.00 | 2023 | |
| Tesaro, INC. | $57.63 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $52.90 | 2019 | |
| Novocure INC. | $46.86 | 2019 | |
| Celgene Corporation | $28.25 | 2019 | |
| Eisai INC. | $16.66 | 2024 | |
| Aveo Pharmaceuticals, INC. | $16.31 | 2025 | |
| Servier Pharmaceuticals LLC | $15.73 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.23 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $12.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Schnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.